IRIS Accounts Production v26.1.10.61 09355671 Board of Directors 1.1.25 31.12.25 31.12.25 17.7.2026 false true false false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093556712024-12-31093556712025-12-31093556712025-01-012025-12-31093556712023-12-31093556712024-01-012024-12-31093556712024-12-3109355671ns15:EnglandWales2025-01-012025-12-3109355671ns14:PoundSterling2025-01-012025-12-3109355671ns10:Director12025-01-012025-12-3109355671ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3109355671ns10:SmallEntities2025-01-012025-12-3109355671ns10:Audited2025-01-012025-12-3109355671ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3109355671ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109355671ns10:FullAccounts2025-01-012025-12-310935567112025-01-012025-12-3109355671ns10:Director22025-01-012025-12-3109355671ns10:RegisteredOffice2025-01-012025-12-3109355671ns5:CurrentFinancialInstruments2025-12-3109355671ns5:CurrentFinancialInstruments2024-12-3109355671ns5:ShareCapital2025-12-3109355671ns5:ShareCapital2024-12-3109355671ns5:RetainedEarningsAccumulatedLosses2025-12-3109355671ns5:RetainedEarningsAccumulatedLosses2024-12-3109355671ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3109355671ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-012025-12-3109355671ns5:ComputerSoftware2025-01-012025-12-3109355671ns5:IntangibleAssetsOtherThanGoodwill2024-12-3109355671ns5:IntangibleAssetsOtherThanGoodwill2025-12-3109355671ns5:IntangibleAssetsOtherThanGoodwill2024-12-3109355671ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3109355671ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31
REGISTERED NUMBER: 09355671 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

PROMEDICA PLUS UK LIMITED

PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PROMEDICA PLUS UK LIMITED

COMPANY INFORMATION
For The Year Ended 31 December 2025







DIRECTORS: K E Twardowska
G Wrzosek





REGISTERED OFFICE: Suite 38 Hardmans Business Centre
New Hall Hey Road
Rawtenstall
Lancashire
BB4 6HH





REGISTERED NUMBER: 09355671 (England and Wales)

PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

BALANCE SHEET
31 December 2025

2025 2024
Notes £    £   
CURRENT ASSETS
Debtors 5 239,457 178,277
Cash at bank 18,054 12,376
257,511 190,653
CREDITORS
Amounts falling due within one year 6 130,768 108,942
NET CURRENT ASSETS 126,743 81,711
TOTAL ASSETS LESS CURRENT
LIABILITIES

126,743

81,711

CAPITAL AND RESERVES
Called up share capital 5,000 5,000
Retained earnings 121,743 76,711
SHAREHOLDERS' FUNDS 126,743 81,711

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 July 2026 and were signed on its behalf by:





G Wrzosek - Director


PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 31 December 2025


1. STATUTORY INFORMATION

Promedica Plus UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is made up of sales of franchise fees and intragroup recharges, excluding value added tax.

Sales of franchise fees are comprised of an initial setup fee, which is recognised on the date the agreement is signed, and ongoing monthly management and marketing fees which are included on a monthly basis with adjustments made for accrued or deferred income.

Intragroup recharges
The company incurs costs throughout the year which relate to the UK based operation and these are recharged monthly to the other UK based trading companies and shown within 'Turnover'.

The recharges are calculated based on the turnover of each individual company as a percentage of the total turnover of all UK trading companies, in line with a formula which is defined in the intercompany agreement. At the end of the year, Management reserve the right to make an adjustment to the recharge to ensure that the costs in each of the individual companies are in line with the turnover of that company.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of one years.

Computer software is being amortised evenly over its estimated useful life of three years.

Financial instruments
The company enters into basic financial instruments, which result in the recognition of financial assets and liabilities. Financial instruments are recognised at amortised cost. At the end of each reporting period financial instruments are assessed for evidence of impairment, and changes are recognised in profit or loss.


PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2025


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods.

Deferred tax represents the future tax consequences of material transactions and events recognised in the financial statements of current and previous periods.

Current and deferred tax assets and liabilities are not discounted and are recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2025
and 31 December 2025 53,105
AMORTISATION
At 1 January 2025
and 31 December 2025 53,105
NET BOOK VALUE
At 31 December 2025 -
At 31 December 2024 -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 10,056 1,517
Balances due from group undertakings 223,028 166,143
Prepayments and accrued income 6,373 10,617
239,457 178,277

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 9,880 1,203
Balances due to group undertakings 15,348 -
Social security and other taxes 43,850 32,436
Accruals and deferred income 61,690 75,303
130,768 108,942

PROMEDICA PLUS UK LIMITED (REGISTERED NUMBER: 09355671)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 31 December 2025


7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Katharine Halsall (Senior Statutory Auditor)
for and on behalf of Caldwell Penn Limited, Statutory Auditor

8. RELATED PARTY DISCLOSURES

At the balance sheet date, the amounts due from and to group companies were as follows:

Due from Promedica24 (Lancashire) Ltd-£223,028(2024 - £166,143)
Due to Promedica24 UK Limited-£15,348(2024 - £nil)

These amounts are included in 'Balances due from group undertakings' and 'Balances due to group undertakings' respectively.

9. ULTIMATE PARENT UNDERTAKING

The ultimate parent undertaking is MetLife, Inc., a company registered in the state of Delaware, USA. The parent's business and mailing address is Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801.